Determinants of favorable treatment outcomes in multidrug-resistant tuberculosis in Zambia: A retrospective cross sectional study, 2018–2022
Dorcas Kalaba, Chitalu Chanda, Muhammad Mputu, Hamooya M Benson, Matenge Mutalange, Lukundo Siame, Sepiso K Masenga, Webster Chewe · 2026
Read Determinants of favorable treatment outcomes in multidrug-resistant tuberculosis in Zambia: A retrospective cross sectional study, 2018–2022 by Dorcas Kalaba, Chitalu Chanda, Muhammad Mputu, Hamooya M Benson, Matenge Mutalange, Lukundo Siame, Sepiso K Masenga, Webster Chewe (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355721.txt.
Description
Dorcas Kalaba and co-authors reviewed outcomes for drug-resistant tuberculosis treatment across Zambia over five years. Success rates sat below the global target, and national evidence on who fares worst was thin. Their 2026 study drew programme records for more than twelve hundred patients treated in all ten provinces.
About two thirds of patients finished with a favourable outcome. Normal body weight more than doubled the odds of success compared with underweight patients. Two provinces, Muchinga and Western, showed markedly lower success odds than the rest. Kalaba and colleagues argue food support and province-targeted fixes are essential if Zambia is to close its resistant-TB outcome gap.
Catalog record
| CREATOR | Dorcas Kalaba, Chitalu Chanda, Muhammad Mputu, Hamooya M Benson, Matenge Mutalange, Lukundo Siame, Sepiso K Masenga, Webster Chewe |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33427 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |